Page last updated: 2024-08-25

bexarotene and Chemo-Fog

bexarotene has been researched along with Chemo-Fog in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arroyo, LD; Chiang, ACA; Heijnen, CJ; Hu, J; Kavelaars, A; Mahalingam, R; Seua, AV; Singhmar, P	1

Other Studies

1 other study(ies) available for bexarotene and Chemo-Fog

Article	Year
Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice. Acta neuropathologica communications, 2020, 11-12, Volume: 8, Issue:1 Topics: Animals; Antineoplastic Agents; Bexarotene; Chemotherapy-Related Cognitive Impairment; Cisplatin; Cognition; Gait; Gene Expression Profiling; Gyrus Cinguli; Mice; Myelin Sheath; Netrins; Neuregulins; Open Field Test; Prefrontal Cortex; Psychomotor Performance; Retinoid X Receptors; RNA-Seq; Sensorimotor Cortex; White Matter	2020

Article

Year

Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice.

Acta neuropathologica communications, 2020, 11-12, Volume: 8, Issue:1

Topics: Animals; Antineoplastic Agents; Bexarotene; Chemotherapy-Related Cognitive Impairment; Cisplatin; Cognition; Gait; Gene Expression Profiling; Gyrus Cinguli; Mice; Myelin Sheath; Netrins; Neuregulins; Open Field Test; Prefrontal Cortex; Psychomotor Performance; Retinoid X Receptors; RNA-Seq; Sensorimotor Cortex; White Matter

2020